Range Low Price High Price Comment
30 days $0.724 $1.23 Tuesday, 30th Apr 2024 DRRX stock ended at $0.96. This is 0.608% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 10.92% from a day low at $0.90 to a day high of $1.00.
90 days $0.680 $1.44
52 weeks $0.470 $7.46

Historical Durect Corporation prices

Date Open High Low Close Volume
Feb 01, 2016 $1.18 $1.21 $1.17 $1.19 257 100
Jan 29, 2016 $1.16 $1.25 $1.16 $1.20 672 900
Jan 28, 2016 $1.17 $1.25 $1.15 $1.16 208 500
Jan 27, 2016 $1.19 $1.26 $1.16 $1.16 314 600
Jan 26, 2016 $1.24 $1.24 $1.12 $1.20 242 000
Jan 25, 2016 $1.30 $1.31 $1.20 $1.21 327 200
Jan 22, 2016 $1.20 $1.32 $1.16 $1.30 379 300
Jan 21, 2016 $1.23 $1.27 $1.16 $1.18 316 100
Jan 20, 2016 $1.15 $1.22 $1.06 $1.21 542 500
Jan 19, 2016 $1.20 $1.26 $1.08 $1.17 486 100
Jan 15, 2016 $1.15 $1.21 $1.12 $1.15 521 500
Jan 14, 2016 $1.27 $1.47 $1.09 $1.19 839 700
Jan 13, 2016 $1.36 $1.56 $1.22 $1.27 450 500
Jan 12, 2016 $1.55 $1.57 $1.34 $1.37 426 800
Jan 11, 2016 $1.60 $1.64 $1.33 $1.47 1 309 900
Jan 08, 2016 $1.80 $1.82 $1.60 $1.60 699 700
Jan 07, 2016 $1.88 $1.96 $1.75 $1.76 330 800
Jan 06, 2016 $2.00 $2.03 $1.88 $1.91 343 400
Jan 05, 2016 $2.04 $2.13 $2.01 $2.03 319 700
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT